[go: up one dir, main page]

AU2011904834A0 - Apricitabine and NRTI combination therapy - Google Patents

Apricitabine and NRTI combination therapy

Info

Publication number
AU2011904834A0
AU2011904834A0 AU2011904834A AU2011904834A AU2011904834A0 AU 2011904834 A0 AU2011904834 A0 AU 2011904834A0 AU 2011904834 A AU2011904834 A AU 2011904834A AU 2011904834 A AU2011904834 A AU 2011904834A AU 2011904834 A0 AU2011904834 A0 AU 2011904834A0
Authority
AU
Australia
Prior art keywords
apricitabine
combination therapy
nrti
nrti combination
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011904834A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tali Digital Ltd
Original Assignee
Avexa Ltd
Filing date
Publication date
Application filed by Avexa Ltd filed Critical Avexa Ltd
Publication of AU2011904834A0 publication Critical patent/AU2011904834A0/en
Abandoned legal-status Critical Current

Links

AU2011904834A 2011-11-18 Apricitabine and NRTI combination therapy Abandoned AU2011904834A0 (en)

Publications (1)

Publication Number Publication Date
AU2011904834A0 true AU2011904834A0 (en) 2011-12-08

Family

ID=

Similar Documents

Publication Publication Date Title
AP2013007178A0 (en) BCMA-based stratification and therapy for multiplemyeloma patients
IL231386A0 (en) Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
ZA201403372B (en) Therapeutic agents and uses thereof
WO2012015937A9 (en) Parp1 targeted therapy
EP2880053B8 (en) Mitigating tissue damage and fibrosis via anti-ltbp4 antibody
IL233238A0 (en) Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application
IL232824A0 (en) Mmp-targeted therapeutic and/or diagnostic nanocarriers
AU2011904834A0 (en) Apricitabine and NRTI combination therapy
AU2011904831A0 (en) Apricitabine and PI combination therapy
ZA201403477B (en) Apricitabine and pi combination therapy
HK1189597A (en) Bicyclic heterocycle compounds and their uses in therapy
AU2011900677A0 (en) Therapeutic and diagnostic agents
AU2011905077A0 (en) Radiotracers and Therapeutic Agents
AU2012900775A0 (en) Therapeutic and diagnostic agents
GB201102210D0 (en) Inventions and therapy
GB201102232D0 (en) Inventions and therapy
GB201102231D0 (en) Inventions and therapy
GB201102236D0 (en) Inventions and therapy
GB201102238D0 (en) Inventions and therapy
GB201102239D0 (en) Inventions and therapy
GB201102228D0 (en) Inventions and therapy
GB201102227D0 (en) Inventions and therapy
GB201102226D0 (en) Inventions and therapy
GB201102234D0 (en) Inventions and therapy
GB201102213D0 (en) Inventions and therapy